These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Sequential synthesis of amino-1,4-naphthoquinone-appended triazoles and triazole-chromene hybrids and their antimycobacterial evaluation. Devi Bala B; Muthusaravanan S; Choon TS; Ashraf Ali M; Perumal S Eur J Med Chem; 2014 Oct; 85():737-46. PubMed ID: 25129868 [TBL] [Abstract][Full Text] [Related]
43. Synthesis and evaluation of a novel quinoline-triazole analogs for antitubercular properties via molecular hybridization approach. Ramprasad J; Kumar Sthalam V; Linga Murthy Thampunuri R; Bhukya S; Ummanni R; Balasubramanian S; Pabbaraja S Bioorg Med Chem Lett; 2019 Oct; 29(20):126671. PubMed ID: 31526604 [TBL] [Abstract][Full Text] [Related]
44. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents. Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612 [TBL] [Abstract][Full Text] [Related]
45. Synthesis and antimycobacterial activity of novel camphane-based agents. Stavrakov G; Philipova I; Valcheva V; Momekov G Bioorg Med Chem Lett; 2014 Jan; 24(1):165-7. PubMed ID: 24332625 [TBL] [Abstract][Full Text] [Related]
46. The antitubercular activity of various nitro(triazole/imidazole)-based compounds. Papadopoulou MV; Bloomer WD; Rosenzweig HS Bioorg Med Chem; 2017 Nov; 25(21):6039-6048. PubMed ID: 28993106 [TBL] [Abstract][Full Text] [Related]
47. Design, synthesis, and antitubercular evaluation of novel series of 3-benzofuran-5-aryl-1-pyrazolyl-pyridylmethanone and 3-benzofuran-5-aryl-1-pyrazolylcarbonyl-4-oxo-naphthyridin analogs. Manna K; Agrawal YK Eur J Med Chem; 2010 Sep; 45(9):3831-9. PubMed ID: 20576327 [TBL] [Abstract][Full Text] [Related]
48. Design of novel dispirooxindolopyrrolidine and dispirooxindolopyrrolothiazole derivatives as potential antitubercular agents. Mhiri C; Boudriga S; Askri M; Knorr M; Sriram D; Yogeeswari P; Nana F; Golz C; Strohmann C Bioorg Med Chem Lett; 2015 Oct; 25(19):4308-13. PubMed ID: 26271585 [TBL] [Abstract][Full Text] [Related]
49. Design, synthesis and in vitro anti-mycobacterial evaluation of gatifloxacin-1H-1,2,3-triazole-isatin hybrids. Xu Z; Zhang S; Song X; Qiang M; Lv Z Bioorg Med Chem Lett; 2017 Aug; 27(16):3643-3646. PubMed ID: 28720502 [TBL] [Abstract][Full Text] [Related]
50. 1-Chloro-2-formyl indenes and tetralenes as antitubercular agents. Chanda D; Saikia D; Kumar JK; Thakur JP; Agarwal J; Chanotiya CS; Shanker K; Negi AS Bioorg Med Chem Lett; 2011 Jul; 21(13):3966-9. PubMed ID: 21641212 [TBL] [Abstract][Full Text] [Related]
51. Synthesis, antitubercular activity, and SAR study of N-substituted-phenylamino-5-methyl-1H-1,2,3-triazole-4-carbohydrazides. Jordão AK; Sathler PC; Ferreira VF; Campos VR; de Souza MC; Castro HC; Lannes A; Lourenco A; Rodrigues CR; Bello ML; Lourenco MC; Carvalho GS; Almeida MC; Cunha AC Bioorg Med Chem; 2011 Sep; 19(18):5605-11. PubMed ID: 21840219 [TBL] [Abstract][Full Text] [Related]
52. 1H-1,2,3-Triazole tethered isatin-moxifloxacin: Design, synthesis and in vitro anti-mycobacterial evaluation. Jiang Y; Qian A; Li Y Arch Pharm (Weinheim); 2019 Jul; 352(7):e1900040. PubMed ID: 31106443 [TBL] [Abstract][Full Text] [Related]
53. Synthesis and evaluation of novel substituted 1,2,3-triazolyldihydroquinolines as promising antitubercular agents. Marvadi SK; Krishna VS; Sriram D; Kantevari S Bioorg Med Chem Lett; 2019 Feb; 29(4):529-533. PubMed ID: 30638877 [TBL] [Abstract][Full Text] [Related]
54. Novel N'-benzylidene benzofuran-3-carbohydrazide derivatives as antitubercular and antifungal agents. Telvekar VN; Belubbi A; Bairwa VK; Satardekar K Bioorg Med Chem Lett; 2012 Mar; 22(6):2343-6. PubMed ID: 22365752 [TBL] [Abstract][Full Text] [Related]
55. Click chemistry approach for bis-chromenyl triazole hybrids and their antitubercular activity. Naik RJ; Kulkarni MV; Sreedhara Ranganath Pai K; Nayak PG Chem Biol Drug Des; 2012 Oct; 80(4):516-23. PubMed ID: 22737986 [TBL] [Abstract][Full Text] [Related]
56. Design, synthesis, and characterization of (1-(4-aryl)- 1H-1,2,3-triazol-4-yl)methyl, substituted phenyl-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylates against Mycobacterium tuberculosis. Venugopala KN; Dharma Rao GB; Bhandary S; Pillay M; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K Drug Des Devel Ther; 2016; 10():2681-90. PubMed ID: 27601885 [TBL] [Abstract][Full Text] [Related]
57. Synthesis of new S-derivatives of clubbed triazolyl thiazole as anti-Mycobacterium tuberculosis agents. Shiradkar MR; Murahari KK; Gangadasu HR; Suresh T; Kalyan CA; Panchal D; Kaur R; Burange P; Ghogare J; Mokale V; Raut M Bioorg Med Chem; 2007 Jun; 15(12):3997-4008. PubMed ID: 17442576 [TBL] [Abstract][Full Text] [Related]
58. Design, synthesis and evaluation of diarylpiperazine derivatives as potent anti-tubercular agents. Penta A; Franzblau S; Wan B; Murugesan S Eur J Med Chem; 2015 Nov; 105():238-44. PubMed ID: 26498570 [TBL] [Abstract][Full Text] [Related]
59. Synthesis and biological evaluation of novel 1,2,3-triazole derivatives as anti-tubercular agents. Aziz Ali A; Gogoi D; Chaliha AK; Buragohain AK; Trivedi P; Saikia PJ; Gehlot PS; Kumar A; Chaturvedi V; Sarma D Bioorg Med Chem Lett; 2017 Aug; 27(16):3698-3703. PubMed ID: 28712709 [TBL] [Abstract][Full Text] [Related]
60. Synthesis and biological evaluation of dihydroquinoline carboxamide derivatives as anti-tubercular agents. Kumar G; Sathe A; Krishna VS; Sriram D; Jachak SM Eur J Med Chem; 2018 Sep; 157():1-13. PubMed ID: 30064024 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]